In vitro susceptibility of dermatophytes to conventional and alternative antifungal agents

Medical Mycology

Volumn 47, Issue 3, 2009, Pages 321-326

  Barchiesi, Francesco ^a   Silvestri, Carmela ^a   Arzeni, Daniela ^a   Ganzetti, Giulia ^a   Castelletti, Sefora ^a   Simonetti, Oriana ^a   Cirioni, Oscar ^a   Kamysz, Wojciech ^b   Kamysz, Elzbieta ^c   Spreghini, Elisabetta ^a   Abruzzetti, Alessandra ^a   Riva, Alessandra ^a   Offidani, Anna M ^a   Giacometti, Andrea ^a   Scalise, Giorgio ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c UNIVERSITY OF GDA SK   (Poland)

Author keywords

Antimicrobial peptides; Dermatophytes; Fluconazole; Lipopeptides

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTIFUNGAL AGENT; FLUCONAZOLE; N TERMINAL PALMITOYL LIPIDATED PEPTIDE; TERPINENE; UNCLASSIFIED DRUG; GAMMA-TERPINENE; LIPOPEPTIDE; TERPENE; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFICACY; FUNGAL BIOMASS; FUNGAL VIABILITY; FUNGUS CULTURE; FUNGUS HYPHAE; FUNGUS ISOLATION; IN VITRO STUDY; MICROSPORUM CANIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; TRICHOPHYTON RUBRUM; ARTHRODERMA; BIOMASS; DRUG EFFECT; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL VIABILITY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MICROSPORUM; MYCOSIS; TRICHOPHYTON;

ARTHRODERMATACEAE; MELALEUCA ALTERNIFOLIA; MICROSPORUM CANIS; TRICHOPHYTON RUBRUM;

ANTIFUNGAL AGENTS; ARTHRODERMATACEAE; BIOMASS; FLUCONAZOLE; HUMANS; LIPOPEPTIDES; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MICROSPORUM; MONOTERPENES; MYCOSES; TETRAZOLIUM SALTS; THIAZOLES; TRICHOPHYTON;

EID: 66449093978     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780802641920     Document Type: Article

References (27)

1. Das S, Goyal R, Bhattacharya SN. Laboratory-based epidemiological study of superficial fungal infections. J Dermatol 2007; 34: 248-253.
2. Ginter-Hanselmayer G, Weger W, Ilkit M, et al. Epidemiology of tinea capitis in Europe: Current state and changing patterns. Mycoses 2007; 50: 6-13.
3. Hernández-Salazar A, Carbajal-Pruneda P, Fernández Martínez R, et al. Dermatophytosis due to Trichophyton rubrum. Ten-year period (1996-2006) data collection in a Dermatology Department in Mexico City. Rev Iberoam Micol 2007; 24: 122-124.
4. Porro AM, Yosioka CN, Kaminski SK, et al. Disseminated dermatophytoses caused by Microsporum gypseum in two patients with the Acquired Immunodeficiency Virus. Mycopathologia 1997; 137: 9-12.
5. Seyfarth F, Ziemer M, Gräser Y, et al. Widespread tinea corporis caused by Trichophyton rubrum with non-typical cultural characteristics-diagnosis via PCR. Mycoses 2007; 50: 26-30.
6. Barchiesi F, Arzeni D, Camilletti V, et al. In vitro activity of posaconazole against clinical isolated of dermatophytes. J Clin Microbiol 2001; 39: 4208-4209.
7. Debruyne D, Coquerel A. Pharmacokinetics of antifungal agents in onychomycoses. Clin Pharmacokinet 2001; 40: 441-472.
8. Fernandez-Torres B, Inza I, Guarro J. Comparison of in vitro antifungal susceptibilities of conidia and hyphae of dermatophytes with thick-wall macroconidia. Antimicrob Agents Chemother 2003; 47: 3371-3372.
9. Fernandez-Torres B, Cabañes FJ, Carrillo-Muñoz AJ, et al. Collaborative study of optimal antifungal susceptibility testing conditions for dermatophytes. J Clin Microbiol 2002; 40: 3999-4003.
10. Fernandez-Torres B, Carrillo AJ, Martin E, et al. In vitro activities of 10 antifungal drugs against 508 dermatophytes strains. Antimicrob Agents Chemother 2001; 45: 2524-2528.
11. Fernandez-Torres B, Vazquez-Veiga H, Liovo X, et al. In vitro susceptibility to itraconazole, clotrimazole, ketoconazole and terbinafine of 100 isolates of Trichophyton rubrum. Chemotherapy 2000; 46: 390-394.
12. Millikan LE. Role of oral antifungal agents for the treatment of superficial fungal infections in immunocompromised patients. Cutis 2001; 68: 6-14.
13. Niewerth M, Korting HC. The use of systemic antimycotics in dermatotherapy. Eur J Dermatol 2000; 10: 155-160.
14. Boudghere-Stambouli O, Merad-Boudia A. Antifungal agents in dermatophytic disease: Failure of griseofulvin, ketoconazole and itraconazole drug resistance dermatomycoses. Bull Soc Pathol Exot 1990; 83: 170-176.
15. Aliò AB, Mendoza M, Zambiano EA, et al. Dermatophytes growth curve and in vitro susceptibility test: A broth microtitration method. Med Mycol 2005; 43: 319-325.
16. Boman HG. Antibacterial peptides: Key components needed in immunity. Cell 1991; 65: 205-207.
17. Hancock R, Chapple DS. Peptides antibiotics. Antimicrob Agent Chemother 1999; 43: 1317-1323.
18. Jenssen H, Hamill P, Hancock RE. Peptide antimicrobial agents. Clin Microbiol Rev 2006; 19: 491-511.
19. Sevcsik E, Pabst G, Jilek A, et al. How lipids influence the mode of action of membrane-active peptides. Biochim Biophys Acta 2007; 1768: 2586-2595.
20. Shai Y. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim Biophys Acta 1999; 1462: 55-70.
21. Carson CF, Hammer KA, Riley TV. Melaleuca alternifolia (Tea Tree) oil: A review of antimicrobial and other medicinal properties. Clin Microbiol Rev 2006; 19: 50-62.
22. Kamysz W, Kochanska B, Kedzia A, et al. Sthaterin SV2 and its analogue. Synthesis and evaluation of antimicrobial activity. Pol J Chem 2002; 76: 801-806.
23. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi; proposed standard. NCCLS document M38-P. 1998 National Committee for Clinical Laboratory Standards, Wayne, PA.
24. Santos DA, Barros MES, Hadan JS. Establishing a method of inoculum preparation for susceptibility testing of Trichophyton rubrum and Trichophyton mentagrophytes. J Clin Microbiol 2006; 44: 98-101.
25. Pfaller MA, Sheehan DJ, Rex JH. Determination of fungicidal activities against yeasts and molds: Lessons learned from bactericidal testing and the need for standardization. Clin Microbiol Rev 2004; 17: 268-280.
26. Bernhard J, Martin E, Stueben A, et al. Susceptibility testing of Candida albicans and Aspergillus species by a sinple microtiter menadione-augmented 3-(4,5-dimethyl-2-thiazol)-2,5-diphenyl-2H-tetrazolium bromide assay. J Clin Microbiol 1995; 33: 661-667.
27. Barchiesi F, Giacometti A, Cirioni O, et al. In vitro activity of the synthetic lipopeptide PAL-Lys-Lys-NH2 alone and in combination with antifungal agents against clinical isolates of Cryptococcus neoformans. Peptides 2007; 28: 1509-1513.